NOTCH3 Mutations in CADASIL Alter Lipid Metabolism: Insights from Patient Plasma and In Vitro Models
Neurochemical Research · 2026-10 · 51 (5)
DOI: 10.1007/s11064-026-04866-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 21.08.2026. Verfasst von Ruihua Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China. Hauptthemen laut MEDLINE: Receptor, Notch3, CADASIL, Lipid Metabolism, Mutation. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, the National Natural Science Foundation of China, Henan Provincial Key Research and Development Special Program.
Abstract (Originalsprache)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common monogenic form of cerebral small vessel disease (CSVD), is caused by mutations in NOTCH3. However, the effects of NOTCH3 mutations on lipid metabolism remain poorly understood. In this study, plasma samples from CADASIL patients and matched healthy controls were subjected to lipidomic analysis. Stable 293T cell lines expressing an empty vector (NC), wild-type (WT) NOTCH3, or CADASIL-associated NOTCH3 mutants (R110C, R133C, R1175W, and R544C), as well as hCMEC/D3 cell lines expressing NC, WT, or R544C, were established to investigate lipid metabolic alterations. Lipid droplet (LD) accumulation, cholesterol levels, and the expression of cholesterol transport-related molecules were assessed. Lipidomic profiling revealed significant alterations in plasma lipid profiles in CADASIL patients compared with healthy controls. In 293T cells, LD accumulation was significantly increased in the R110C, R1175W, and R544C groups, but not in the R133C group, whereas cholesterol levels were elevated in all mutant groups. In hCMEC/D3 cells, expression of the R544C mutant markedly promoted cholesterol accumulation and reduced the expression of the cholesterol transporters ABCA1 and ABCG1. These findings indicate that NOTCH3 mutations are associated with disrupted cellular lipid homeostasis and suggest that lipid metabolic dysregulation may represent a potential mechanism contributing to CADASIL pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China.
- Department of Neurology, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai, Shanghai University of Traditional Chinese Medicine, 181 Youyi Road, Shanghai, 201900, China.
- Department of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Neurology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China. edu1563820@163.com.
- Department of Orthopedics, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China. huangyifandoc@163.com.
- Department of Neurology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China. zhangjiewen9900@126.com.
Förderung
- Natural Science Foundation of Henan Province
- the National Natural Science Foundation of China
- Henan Provincial Key Research and Development Special Program
- Henan Provincial Major Project of Medical Science and Technology Key Research Program under Provincial-Ministerial Co-Construction
Zitieren
APA
Sun, R., Ji, X., Hu, W., Li, W., Zhao, Y., Wang, W., Lu, Y., Li, A., Huang, Y., & Zhang, J. (2026). NOTCH3 Mutations in CADASIL Alter Lipid Metabolism: Insights from Patient Plasma and In Vitro Models. Neurochemical Research, 51(5). https://doi.org/10.1007/s11064-026-04866-9
Vancouver
Sun R, Ji X, Hu W, Li W, Zhao Y, Wang W, et al. NOTCH3 Mutations in CADASIL Alter Lipid Metabolism: Insights from Patient Plasma and In Vitro Models. Neurochemical Research. 2026;51(5). doi:10.1007/s11064-026-04866-9
BibTeX
@article{Sun2026,
author = {Sun, Ruihua and Ji, Xiaoyi and Hu, Wenjian and Li, Wanyue and Zhao, Ying and Wang, Wan and Lu, Yaru and Li, Anqi and Huang, Yifan and Zhang, Jiewen},
title = {NOTCH3 Mutations in CADASIL Alter Lipid Metabolism: Insights from Patient Plasma and In Vitro Models},
journal = {Neurochemical Research},
year = {2026},
volume = {51},
number = {5},
doi = {10.1007/s11064-026-04866-9}
}
EUVIMED